Since the first identification of single-domain antibodies or sdAbs in the sera of Camelidae, they have been increasingly recognized as a class of next-generation antibodies due to attractive features, such as nanoscale small size, high penetration, high stability, and ease of production. As the smallest antibody fragment with binding ability, single-domain antibodies have been in the interest of many… Read more »
Posts Categorized: Biotechnology
Deadline Approaching for 2022 Creative Biolabs Scholarship Program
Earlier this year, Creative Biolabs announced its 2022 Scholarship Program. Global students majoring in Biology, Biochemistry, Chemistry, and Molecular Biology may be eligible for a scholarship through Creative Biolabs’ scholarship program, as long as they enrolled at an accredited college or university. This program awards up to $1000 to the most excellent applicant to support… Read more »
Creative Biolabs Echoes White House’s Efforts in Next-Generation COVID-19 Vaccine Development
News reports that the Biden administration officials hold a summit discussing the lofty goal of the White House to develop the next-generation COVID-19 vaccines. This extensive initiative aims at novel immunization development to curb the infection or transmission of future SARS-CoV-2 variants. As one of the major forces in vaccine discovery and development, Creative Biolabs praises the… Read more »
Creative Biolabs: Leap Beyond Conventional Membrane Protein Discovery
Membrane proteins are valuable assets to drug discovery as their functions are involved in extensive biological processes in the human body, such as ligand-receptor binding, signal transduction, transportation of molecules, and intracellular recognition. Creative Biolabs is a conscientious contract research organization working in biotechnology areas with a particular emphasis on protein discovery, which helps design… Read more »
Creative Biolabs Sets Sights on Single-Domain Antibodies’ Protection Against COVID-19
The findings recently published in Cell Reports described that immune particles derived from llamas’ blood have the potential to provide protection against Omicron, SARS-CoV-2, and other 18 COVID-19 variants. Scientists at Creative Biolabs nod at this study as special VHH antibodies (or single-domain antibodies, sdAbs) produced by llamas, camels, and alpacas only have a single… Read more »
